Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Generating synthetic data from administrative health records for drug safety and effectiveness studies

dc.contributor.authorAyilara, Olawale
dc.contributor.authorPlatt , Robert W.
dc.contributor.authorDahl, Matthew
dc.contributor.authorCoulombe, Janie
dc.contributor.authorGinestet, Pablo Gonzalez
dc.contributor.authorChateau, Dan
dc.contributor.authorLix, Lisa
dc.date.accessioned2024-06-17T22:42:48Z
dc.date.available2024-06-17T22:42:48Z
dc.date.issued2023
dc.date.updated2024-05-19T08:17:55Z
dc.description.abstractIntroduction Administrative health records (AHRs) are used to conduct population-based post-market drug safety and comparative effectiveness studies to inform healthcare decision making. However, the cost of data extraction, and the challenges associated with privacy and securing approvals can make it challenging for researchers to conduct methodological research in a timely manner using real data. Generating synthetic AHRs that reasonably represent the real-world data are beneficial for developing analytic methods and training analysts to rapidly implement study protocols. We generated synthetic AHRs using two methods and compared these synthetic AHRs to real-world AHRs. We described the challenges associated with using synthetic AHRs for real-world study. Methods The real-world AHRs comprised prescription drug records for individuals with healthcare insurance coverage in the Population Research Data Repository (PRDR) from Manitoba, Canada for the 10-year period from 2008 to 2017. Synthetic data were generated using the Observational Medical Dataset Simulator II (OSIM2) and a modification (ModOSIM). Synthetic and real-world data were described using frequencies and percentages. Agreement of prescription drug use measures in PRDR, OSIM2 and ModOSIM was estimated with the concordance coefficient. Results The PRDR cohort included 169,586,633 drug records and 1,395 drug types for 1,604,734 individuals. Synthetic data for 1,000,000 individuals were generated using OSIM2 and ModOSIM. Sex and age group distributions were similar in the real-world and synthetic AHRs. However, there were significant differences in the number of drug records and number of unique drugs per person for OSIM2 and ModOSIM when compared with PRDR. For the average number of days of drug use, concordance with the PRDR was 16% (95% confidence interval [CI]: 12%-19%) for OSIM2 and 88% (95% CI: 87%-90%) for ModOSIM. Conclusions ModOSIM data were more similar to PRDR than OSIM2 data on many measures. Synthetic AHRs consistent with those found in real-world settings can be generated using ModOSIM. Synthetic data will benefit rapid implementation of methodological studies and data analyst training.
dc.description.sponsorshipThis research was supported by funding from the Canadian Institutes of Health Research (Funding Reference NumberDSE-146021)
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn23994908
dc.identifier.urihttps://hdl.handle.net/1885/733713252
dc.language.isoen_AUen_AU
dc.provenanceThis work is licensed under a Creative Commons Attribution 4.0 International License.
dc.publisherSwansea University, UK
dc.rights© 2023 The authors
dc.rights.licenseCreative Commons Attribution licence
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceInternational Journal of Population Data Science
dc.titleGenerating synthetic data from administrative health records for drug safety and effectiveness studies
dc.typeJournal article
dcterms.accessRightsOpen Access
local.bibliographicCitation.issue1
local.bibliographicCitation.lastpage12
local.bibliographicCitation.startpage1
local.contributor.affiliationAyilara, Olawale, Department of Community Health Sciences
local.contributor.affiliationPlatt , Robert W., McGill University
local.contributor.affiliationDahl, Matthew, University of Manitoba
local.contributor.affiliationCoulombe, Janie, Department of Mathematics and Statistics
local.contributor.affiliationGinestet, Pablo Gonzalez, Department of Medical Epidemiology and Biostatistics
local.contributor.affiliationChateau, Dan, College of Health and Medicine, ANU
local.contributor.affiliationLix, Lisa, Department of Community Health Sciences, University of Manitoba
local.contributor.authoruidChateau, Dan, u1104823
local.description.notesImported from ARIES
local.identifier.absfor321400 - Pharmacology and pharmaceutical sciences
local.identifier.ariespublicationa383154xPUB46521
local.identifier.citationvolume8
local.identifier.doi10.23889/ijpds.v8i1.2176
local.identifier.scopusID2-s2.0-85182240596
local.publisher.urlhttps://ijpds.org/
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpds-06-2176.pdf
Size:
2.31 MB
Format:
Adobe Portable Document Format